SCHEMBL14437459

SCHEMBL14437459

COCCOc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(CI)c3)c2cc1C(N)=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.68
RET P07949 6/20 0.68
FGFR4 P22455 6/20 0.68
PDGFRA P16234 4/20 0.68
AURKB Q96GD4 4/20 0.68
FGFR1 P11362 4/20 0.68
PDGFRB P09619 3/20 0.68
KIT P10721 3/20 0.68
FGFR2 P21802 3/20 0.68
FGFR3 P22607 3/20 0.68
FLT1 P17948 2/20 0.68
FLT4 P35916 2/20 0.68
ABL1 P00519 2/20 0.68
RIPK2 O43353 1/20 0.68
ERN1 O75460 1/20 0.68
STK10 O94804 1/20 0.68
MAP3K6 O95382 1/20 0.68
ESR1 P03372 1/20 0.68
ADORA3 P0DMS8 1/20 0.68
BCR P11274 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL864039 0.89 KDR (0.69) KDRRETFGFR4PDGFRAAURKB
SCHEMBL864156 0.89 FGFR4 (0.85) KDRRETFGFR4PDGFRAAURKB
SCHEMBL14693157 0.89 FGFR4 (0.61) KDRRETFGFR4PDGFRAAURKB
SCHEMBL25779446 0.86 KDR (0.80) KDRRETFGFR4PDGFRAAURKB
SCHEMBL863807 0.86 AXL (0.69) KDRRETFGFR4PDGFRAAURKB
SCHEMBL14437494 0.86 FGFR4 (0.65) KDRRETFGFR4PDGFRAAURKB
SCHEMBL14437868 0.85 FGFR4 (0.63) KDRRETFGFR4PDGFRAAURKB
SCHEMBL14437500 0.85 KDR (0.63) KDRRETFGFR4PDGFRAAURKB
SCHEMBL14693165 0.84 FGFR4 (0.59) KDRRETFGFR4PDGFRAAURKB
SCHEMBL14693169 0.82 KDR (0.58) KDRRETFGFR4PDGFRAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed